Zhejiang Conba Pharmaceutical Co (SHSE:600572) EBIT per Share : ¥0.25 (TTM As of Sep. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Zhejiang Conba Pharmaceutical Co EBIT per Share?

Zhejiang Conba Pharmaceutical Co's EBIT per Share for the three months ended in Sep. 2024 was ¥0.07. Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.25.

During the past 12 months, the average EBIT per Share Growth Rate of Zhejiang Conba Pharmaceutical Co was -32.10% per year. During the past 3 years, the average EBIT per Share Growth Rate was 3.90% per year. During the past 5 years, the average EBIT per Share Growth Rate was -5.80% per year. During the past 10 years, the average EBIT per Share Growth Rate was 1.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Zhejiang Conba Pharmaceutical Co's EBIT per Share or its related term are showing as below:

SHSE:600572' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -10 Med: 8.1 Max: 48.4
Current: 3.9

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Zhejiang Conba Pharmaceutical Co was 48.40% per year. The lowest was -10.00% per year. And the median was 8.10% per year.

SHSE:600572's 3-Year EBIT Growth Rate is ranked worse than
56.1% of 836 companies
in the Drug Manufacturers industry
Industry Median: 6.8 vs SHSE:600572: 3.90

Zhejiang Conba Pharmaceutical Co's EBIT for the three months ended in Sep. 2024 was ¥170 Mil.

Zhejiang Conba Pharmaceutical Co EBIT per Share Historical Data

The historical data trend for Zhejiang Conba Pharmaceutical Co's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Conba Pharmaceutical Co EBIT per Share Chart

Zhejiang Conba Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.04

0.35

1.01

0.25

0.31

Zhejiang Conba Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT per Share	Get a 7-Day Free Trial															0.06	-0.01	0.11	0.09	0.07

Zhejiang Conba Pharmaceutical Co EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Zhejiang Conba Pharmaceutical Co's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	804.093	/	2572.056
=	0.31

Zhejiang Conba Pharmaceutical Co's EBIT per Share for the quarter that ended in Sep. 2024 is calculated as

	EBIT per Share		(Q: Sep. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	169.859	/	2491.202
=	0.07

EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.25

Zhejiang Conba Pharmaceutical Co (SHSE:600572) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Zhejiang Conba Pharmaceutical Co EBIT per Share Related Terms

Thank you for viewing the detailed overview of Zhejiang Conba Pharmaceutical Co's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Conba Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Conba Pharmaceutical Co Ltd (SHSE:600572) » Definitions » EBIT per Share

Traded in Other Exchanges

N/A

Address

No. 568 Binkang Road, New and High-Technology Development Zone, Binjiang District, Zhejiang, Hangzhou, CHN, 310052

Website

http://www.conba.com.cn

Zhejiang Conba Pharmaceutical Co Ltd operates as a pharmaceutical company in China. It offers traditional Chinese medicines, botanical extracts, chemical medicines, chemical raw medicines, health foods, common foods, prepared drugs in pieces, and commodities. It provides its products under the Conba, Prostate Plus, Zhenshiming, Tianbaoning, Alocin, Xitao, Yuanbang, Baby, and Omeprazole names.

Executives

Hu Ji Qiang	Director
Yuan Zhen Xian	senior management
Yin Shi Shui	Supervisors
Xu Chun Ling	senior management
Jin Zu Cheng	Directors, senior managers
Ye Jian Feng	Supervisors
Ying Chun Xiao	Director
Chen Ming	Director
Luo Guo Liang	Director
Wu Zhong Shi	Supervisors
Wang Ru Wei	Director
Yang Jun De	senior management
Yang Xian Min	senior management
Chen Yue Zhong	senior management
Li Jian Zhong	Supervisors

Zhejiang Conba Pharmaceutical Co Headlines

No Headlines